Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone
Authors:
- K.J ThongKTK.J Thong
- D.T BairdDBD.T Baird
- 1 November 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 338 (8777) , 1233-1236
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Misoprostol and congenital malformationsThe Lancet, 1991
- Uterine activity and decidual prostaglandin production in women in early pregnancy in response to mifepristone with or without indomethacin in vivoHuman Reproduction, 1991
- A death associated with mifepristone/ sulprostoneThe Lancet, 1991
- Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancyContraception, 1990
- CARDIAC STANDSTILL INDUCED BY PROSTAGLANDIN PESSARIESThe Lancet, 1989
- INDUCTION OF THERAPEUTIC ABORTION IN EARLY PREGNANCY WITH MIFEPRISTONE IN COMBINATION WITH PROSTAGLANDIN PESSARYThe Lancet, 1987
- Chemistry and synthetic development of misoprostolDigestive Diseases and Sciences, 1985
- Progesterone receptor blockageContraception, 1985
- Influence of the position of the side chain hydroxy group on the gastric antisecretory and antiulcer actions of E1 prostaglandin analogsProstaglandins, 1975
- EFFECTS OF ORAL ADMINISTRATION OF PROSTAGLANDINS E2 AND F2α ON THE HUMAN UTERUSBJOG: An International Journal of Obstetrics & Gynaecology, 1971